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PML and several other proteins localizing in PML-
nuclear bodies (PML-NB) contain phosphoSIMs
(SUMO-interacting motifs), and phosphorylation of
this motif plays a key role in their interaction with
SUMO family proteins. We examined the role that
phosphorylation plays in the binding of the phospho-
SIMs of PML and Daxx to SUMO1 at the atomic level.
The crystal structures of SUMO1 bound to un-
phosphorylated and tetraphosphorylated PML-SIM
peptides indicate that three phosphoserines di-
rectly contact specific positively charged residues
of SUMO1. Surprisingly, the crystal structure of
SUMO1 bound to a diphosphorylated Daxx-SIMpep-
tide indicate that the hydrophobic residues of the
phosphoSIM bind in a manner similar to that seen
with PML, but important differences are observed
when comparing the phosphorylated residues.
Together, the results provide an atomic level descrip-
tion of how specific acetylation patterns within
different SUMO family proteins can work together
with phosphorylation of phosphoSIM’s regions of
target proteins to regulate binding specificity.
INTRODUCTION
Like ubiquitin, SUMO proteins (SUMO 1–3) can be covalently
attached to lysine residues in target proteins through a post-
translational modification that involves three enzymatic reac-
tions (Desterro et al., 1999; Kahyo et al., 2001; Pichler et al.,
2002). One important feature that regulates the overall SUMOy-
lation pathway is the existence of SUMO-binding domains
(SBDs) that mediate noncovalent protein-protein interactions
with either SUMO family proteins or proteins that have been
SUMOylated. Although numerous ubiquitin-binding domains
(UBDs) have been identified (Husnjak and Dikic, 2012),
only two types of SBDs have been characterized to date; a126 Structure 23, 126–138, January 6, 2015 ª2015 Elsevier Ltd All rigSUMO-specific zinc-finger domain (ZZ-zinc finger) (Danielsen
et al., 2012) and the more prevalent SUMO-interacting motif
(SIM) (Song et al., 2004). The minimal core of the SIM is char-
acterized by a short sequence composed predominantly of
hydrophobic residues, JJJJ, JxJJ, or JJxJ (where J
is V, I, or L and x is typically D, E, S, or T) (Gareau and Lima,
2010). Upon binding to SUMO proteins, the SIM forms either
a parallel or an antiparallel b strand configuration with the
second b strand of SUMO proteins, and the orientation of the
SIM (parallel versus antiparallel) toward a specific SUMO pro-
tein is thought to be dictated by acidic and/or phosphorylated
amino acid residues juxtaposed to the hydrophobic core of the
SIM (Gareau and Lima, 2010; Gareau et al., 2012; Song et al.,
2005).
The best-characterized interactions involving SIMs and either
SUMO proteins or SUMOylated proteins occurs during promye-
locytic leukemia (PML)-dependent recruitment of proteins into
subnuclear structures known as PML-nuclear bodies (PML-
NBs) (Cho et al., 2009; Ishov et al., 1999; Lin et al., 2006;
Rasheed et al., 2002; Sung et al., 2011). PML is implicated in
regulating a wide range of biological processes, including tran-
scription, cell cycle control, and genome integrity (Dellaire and
Bazett-Jones, 2007; Salomoni et al., 2012; Zhong et al., 2000).
Due to alternative splicing, the PML gene gives rise to several
protein isoforms (Jensen et al., 2001), and all nuclear PML iso-
forms, except PML-VI, have a SIM and are components of
PML-NBs (Maroui et al., 2012; Weidtkamp-Peters et al., 2008).
Although the function of the PML-NBs remains enigmatic, it is
known that a wide variety of proteins transit in and out of PML-
NBs dynamically in response to different stimuli, including onco-
genic stress, radiation damage, cytokine signaling, and viral
infection (Lallemand-Breitenbach and de The´, 2010). Interest-
ingly, PML plays a key role in regulating the transit of these
proteins through noncovalent interactions between its SIM and
SUMOylated proteins or by the fact that it is SUMOylated and in-
teracts with other proteins that contain SIMs (Chen et al., 2008;
Dellaire et al., 2006; Everett et al., 1999; Salomoni et al., 2005;
Weidtkamp-Peters et al., 2008).
The SIM found in PML is composed of four hydrophobic resi-
dues (VVVI) followed by a cluster of serine and acidic residues
(Shen et al., 2006; Song et al., 2004). Within the serine/acidichts reserved
Structure
Structure of the PhosphoSIM of PML Bound to SUMO1residue-rich cluster, there are three consensus casein kinase 2
(CK2)-phosphorylation sites, and a fourth consensus CK2-phos-
phorylation site is generated subsequent to phosphorylation of
the C-terminal site (Scaglioni et al., 2006; Rabellino et al.,
2012). Initially, it was suggested that PML degradation rates
are enhanced by phosphorylation of these serine residues based
on the observation that blocking phosphorylation of these resi-
dues by mutating them to alanine significantly enhanced PML
stability (Scaglioni et al., 2006). In addition, several tumor-
derived cell lines displayed an inverse relationship between their
CK2 activity and their levels of PML protein (Scaglioni et al.,
2006, 2008; Rabellino et al., 2012). Of note, mutating the serines
to alanines led to a decrease in PMLbinding to SUMO1 aswell as
an enhancement of PML-driven apoptosis (Percherancier et al.,
2009; Scaglioni et al., 2006; Stehmeier and Muller, 2009). These
results suggest that several PML functions can be regulated by
varying the phosphorylation status of the serine residues adja-
cent to the hydrophobic core of the SIM and that the two adja-
cent segments work together as a phosphoSIM.
Like PML, a number of other proteins that transit into PML-
NBs, including Daxx and PIAS1, contain a phosphoSIM module,
and their noncovalent interaction with SUMOproteins are known
to be regulated in a phosphorylation-dependent manner (Cho
et al., 2009; Lin et al., 2006; Negorev et al., 2001; Rasheed
et al., 2002; Sung et al., 2011). Based on studies analyzing inter-
actions between SUMO proteins and phosphoSIM-containing
proteins, it has been postulated that the phosphorylated resi-
dues make contacts with positively charged surface residues
that are conserved in SUMO family proteins (Chang et al.,
2011; Sekiyama et al., 2008; Song et al., 2005; Stehmeier and
Muller, 2009; Ullmann et al., 2012). In the case of SUMO1, it
has been suggested that K37, K39, H43, K45, and K46 may
make important contacts based on mutational analysis. In addi-
tion, it has been demonstrated that the interaction between
phosphoSIMs and SUMO family proteins may be further regu-
lated in a posttranslational manner through acetylation of
SUMO family proteins at several of these same lysine residues
(Cheema et al., 2010; Choudhary et al., 2009; Ullmann et al.,
2012). In particular, SUMO1 acetylated at K37 (K33 in SUMO2)
displayed a decreased affinity for the phosphoSIMs of numerous
proteins (Ullmann et al., 2012).
Given the important role that phosphorylation of PML plays in
regulating its function, we have used a combination of functional,
biochemical, and structural studies to characterize the interac-
tion between the phosphoSIM of PML and SUMO1 at the atomic
level. We establish that the interaction between SUMO1 and
PML is strongly enhanced by phosphorylation of the four serine
residues of the phosphoSIM of PML. Structural characterization
of SUMO1 in complex with a phosphoSIM peptide of PML in
both its unphosphorylated and tetraphosphorylated forms indi-
cates that three of the four phosphoserine residues directly
interact with positively charged residues of SUMO1, and muta-
tion of these positively charged residues within SUMO1 sig-
nificantly decreases its interaction with PML in human cells. In
addition, structural characterization of a phosphoSIM peptide
of Daxx in both its unphosphorylated and diphosphorylated
forms indicates that the hydrophobic residues have similar inter-
actions, but the acidic/phosphorylated residues have different
interactions with SUMO1. Together, these results provide anStructure 23, 12atomic level description of the role of phosphorylation of PML
in PML interaction with SUMO proteins, as well as important in-
sights into how different spacing patterns of acidic/phosphory-
lated residues within phosphoSIMs can interconnect with the
acetylation patterns of the different SUMO family proteins to
define specificity.
RESULTS
Blocking Phosphorylation of PML Decreases
Noncovalent Binding to SUMO Proteins in Cells
Previous studies have shown that four serine residues (S560,
S561, S562, and S565 in PML-I) in the phosphoSIM of PML
are phosphorylated and substituting these residueswith aspartic
acid enhanced PML binding to SUMO1 (Percherancier et al.,
2009; Scaglioni et al., 2006; Stehmeier and Muller, 2009; Rabel-
lino et al., 2012). In addition, the phosphoSIM of PML is
conserved in most PML isoforms and several other proteins
found in PML-NBs have similar phosphoSIM sequences (Fig-
ure 1A; Figure S1 available online). To confirm the role of the
PML phosphoSIM for noncovalent binding to SUMO1 in human
cells, we measured the interaction between wild-type PML, a
nonphosphorylable mutant of PML (PML-4SA; four serines
mutated to alanines), and a phosphomimetic mutant of PML
(PML-4SD; four serines mutated to aspartic acid) with a noncon-
jugable version of SUMO1 (GFP-SUMO1; two C-terminal gly-
cines mutated to alanine) using bioluminescence resonance
energy transfer (BRET) (Figure 1B).
HEK293T cells were cotransfected with a fixed quantity of
DNA coding for either the wild-type PML (PML-Rluc), the non-
phosphorylable mutant (PML-4SA-RLuc), or the phosphomi-
metic mutant (PML-4SD-Rluc) fused to Renilla luciferase along
with increasing amounts of a DNA coding for GFP-SUMO1. For
wild-type PML, the BRET ratio increased as a function of GFP-
SUMO1 concentration and reached a maximum when the
GFP-SUMO1 expression levels were no longer limiting relative
to the PML-Rluc expression levels (Figure 1C). The saturation
curve indicated a specific noncovalent interaction between
PML and SUMO1 under our experimental conditions, since the
GFP-SUMO1 was nonconjugable. In contrast, a significantly
lower BRET signal was obtained for the interaction between
PML-4SA-Rluc and GFP-SUMO1 (Figure 1C). This indicated a
weaker interaction between PML-4SA and SUMO1 and sug-
gested that phosphorylation events targeting the serine residues
of PML could bemodulating the SUMO1:PML noncovalent inter-
actions. Next, we measured the interaction between SUMO1
and the phosphomimetic PML mutant. A BRET saturation curve
similar to the one of the wild-type PML was obtained between
PML-4SD-Rluc and GFP-SUMO1 (Figure 1C). This result de-
monstrated that replacing the alanine residues with the nega-
tively charged aspartic acid restored the ability of PML to interact
with SUMO1 in HEK293T cells. Moreover, it suggested that the
serine residues within the SIMmodule of PMLmay be phosphor-
ylated in HEK293 cells. This would be consistent with previous
studies demonstrating that the fourth serine (S565) within the
phosphoSIM of PML is significantly phosphorylated in HEK293
cells, and that phosphorylation at S565 triggers the subsequent
phosphorylation of positions S560, S561, and S562 (Scaglioni
et al., 2006;Rabellino et al., 2012).6–138, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 127
Figure 1. Interaction between SUMO1 and PML in HEK293T Cells
(A) Schematic representation of PML domains (human PML-I) and sequence
alignment of the phosphoSIM regions of PML from different eukaryotic spe-
cies. The domains and regions indicated as boxes in the schematic repre-
sentation include the Really Interesting New Gene (RING) domain (light gray),
the B1 and B2 B-box domains (medium gray), the coiled-coil domain (dark
gray), and the phosphoSIM module (black). In the alignment of the PML
phosphoSIM region: y, CK2-concensus sites; *, identical residues in the
aligned sequences; and ., homologous residues.
(B) Amino-acid sequence of phosphoSIMmutants used for BRET studies. The
residues mutated are in italics and underlined.
(C) Representative BRET titration curves showing interaction between SUMO1
and either wild-type PML or mutants in HEK293T cells. The PML-RLuc (-),
PML-4SD-Rluc (6), and PML-4SA-Rluc (7) were used with GFP-SUMO1.
See also Figure S1.
Structure
Structure of the PhosphoSIM of PML Bound to SUMO1Phosphorylation of PML SIM Enhances Binding to
SUMO1 In Vitro
As the BRET results supported previous studies suggesting that
phosphorylation of the phosphoSIM in PML modulates its inter-128 Structure 23, 126–138, January 6, 2015 ª2015 Elsevier Ltd All rigaction with SUMO1 (Percherancier et al., 2009; Scaglioni et al.,
2006; Stehmeier and Muller, 2009; Rabellino et al., 2012), we at-
tempted to quantitatively address the role that phosphorylation
has on the binding of PML to SUMO1 in vitro. For these studies,
two peptides corresponding to residues 547–573 of PML-I were
prepared and their apparent dissociation constants (KD) for bind-
ing to SUMO1 measured by isothermal titration calorimetry (ITC)
(Figure 2A). These peptides encompass the phosphoSIM
including both the hydrophobic region (V556, V557, V558, and
I559) and the serine residues (560, 561, 562, and 565) that are
phosphorylated in PML (Figure 2B). The first peptide contained
the wild-type PML sequence (PML-SIM), whereas in the second
peptide S560, S561, S562, and S565 were phosphorylated
(PML-SIM-PO4). In the ITC assay, the PML-SIM peptide bound
SUMO1with a KD of 44 ± 5 mM, whereas the PML-SIM-PO4 pep-
tide bound with a 37-fold higher affinity and a KD of 1.2 ± 0.2 mM
(Figure 2C). Taken together, the in vitro ITC results strongly sup-
port that phosphorylation of the four serine residues present in
the phosphoSIM of PML significantly enhances the noncovalent
binding of PML to SUMO1.
SUMO1 Lysine Residues Are Essential for the
SUMO1:PML Interaction
As mentioned above, the region of SUMO1 spanning from the
end of b2 to the start of the a1 contains two positively charged
patches that are conserved in all SUMO proteins and have
been shown to be important for binding to phosphoSIM motifs
(Chang et al., 2011; Sekiyama et al., 2008; Song et al., 2005;
Stehmeier and Muller, 2009; Ullmann et al., 2012). The first posi-
tively charged patch of SUMO1 includes K37 and K39 and the
second patch contains K45 and K46 (Figure 3A). To determine
the importance of positively charged residues for SUMO1 bind-
ing to full-length PML in human cells, we generated a series of
lysine to alanine mutants within these two positively charged
patches of SUMO1 [SUMO1-K37A-K39A, SUMO1-K45A-46A
and SUMO1-K37A-K39A-K45A-K46A (SUMO1-4KA)] and
tested their ability to bind PML using our BRET assay. In compar-
ison to the BRET signal observed between wild-type PML-RLuc
and GFP-SUMO1, a significant decrease was observed in the
BRET signals for the interactions between PML-RLuc and either
the GFP-SUMO1-K37A-K39A, GFP-SUMO1-K45A-K46A, or
GFP-SUMO1-4KAmutant in HEK293T cells (Figure 3B). Interest-
ingly, the decrease in the intensity of the BRET signal was similar
for the three mutants tested, and this suggested that the two
basic patches function in unison to achieve optimal binding to
PML with the four lysine residues of SUMO1, contributing in
both direct and indirect manners.
K39, H43, and K46 of SUMO1 Contact with the
PML-SIM-PO4 Peptide
Tomore precisely identify positively charged residues of SUMO1
that specifically interact with the phosphorylated serine residues
in the PML-SIM-PO4 peptide, chemical shift perturbation studies
were performed using nuclear magnetic resonance (NMR) spec-
troscopy. In these studies, 1H-15N heteronuclear single quantum
coherence (HSQC) experiments were conducted with 15N-
labeled SUMO1 and either the PML-SIM peptide or the PML-
SIM-PO4 peptide. As expected, the sequential addition of either
peptide resulted in changes in both the 1H and 15N chemicalhts reserved
Figure 3. SUMO1 Lysine Residues Are Critical for PML:SUMO1
Interaction
(A) Ribbon model of the 3D structure of SUMO1 (light gray; PDB ID 2UYZ) with
lysine residues from the two basic patches highlighted as sticks.
(B) Representative BRET titration curves showing interaction between either
wild-type SUMO1 or the SUMO1 basic patch mutants and PML in HEK293T
cells. PML-RLuc was used with GFP-SUMO1 (-), GFP-SUMO1-K37-39A
(B), GFP-SUMO1-K45-46A (+), or GFP-SUMO1-4KA (*).
Figure 2. Phosphorylation of PML Enhances Interaction with
SUMO1
(A) Representative ITC thermogram for the interaction between SUMO1 and
the PML-SIM peptide.
(B) Amino-acid sequences of the PML-SIM and the PML-SIM-PO4 peptides
used in the ITC studies.
(C) Comparison of the dissociation constant (KD) values for SUMO1 binding to
the PML-SIM and PML-SIM-PO4 peptides in the ITC studies.
Structure
Structure of the PhosphoSIM of PML Bound to SUMO1shifts for several signals of SUMO1 (Figure S2). Superimposition
of the 1H-15N HSQC spectra from the two titrations after the
addition of one equivalent of peptide revealed several important
differences (Figure 4A). These differences indicated that specific
chemical shift perturbations were occurring in SUMO1 upon
interaction with the PML-SIM-PO4 peptide (Figure 4B) due to
the presence of the phosphoserine residues. The most signifi-Structure 23, 12cant differences occured at signals corresponding to residues
located primarily in the region of SUMO1, spanning from the
end of its second b strand (b2) to themiddle of its a helix (a1) (Fig-
ures 4B and 4C). This region of SUMO1 includes the two posi-
tively charged patches, and K39, H43, and K46 within this region
showed the most dramatic differences when comparing the
1H-15N HSQC spectra obtained with the PML-SIM peptide with
that of the PML-SIM-PO4 peptide (Figure 4B). Interestingly,
these results are similar to what was observed in NMR studies
between SUMO1 and peptides corresponding to the phospho-
SIM of Daxx, where the most dramatic chemical shift changes
following phosphorylation were observed for V38, K39, and
H43 (Chang et al., 2011). Consistent with the BRET and ITC
studies, the NMR chemical shift perturbation studies supported
the notion that phosphorylation of the phosphoSIM from PML
enhances its affinity for SUMO1 and that phosphorylated resi-
dues from the phosphoSIM of PML contact a number of posi-
tively charged amino acids in SUMO1.6–138, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 129
Figure 4. Positively Charged Residues in SUMO1 Make Specific
Interactions with the PML-SIM-PO4 Peptide
(A) Overlay from the 2D 1H-15N HSQC spectra of 15N-labeled SUMO1 in the
presence of one molar equivalent of either the unlabeled PML-SIM (blue) or
PML-SIM-PO4 peptide (pink).
(B) Histogramof thedifferences in chemical shift perturbations (CSP) that occur
in the titration between 15N-labeled SUMO1 and the PML-SIM-PO4 peptide
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To gain structural insights into the role that phosphorylation of
the phosphoSIM of PML has on its noncovalent interaction
with SUMO1, we crystallized an N-terminal truncated form of
SUMO1 (DN-SUMO1; residues 17–97 of human SUMO1) in
complex with the PML-SIM-PO4 peptide. The crystals belong
to the P212121 space group, diffract to a resolution of 1.50 A˚,
and contain one DN-SUMO1:PML-SIM-PO4 complex in the
asymmetric unit (Table 1). Clear density was visible for residues
18–94 of SUMO1, residues 552–562 (Figure 5), and 569–573
(Figure S3) of PML. In complex with the PML-SIM-PO4 peptide,
SUMO1 adopted a canonical ubiquitin-like fold, whereas the
PML-SIM-PO4 peptide adopted a parallel b strand conformation
with respect to the second b strand (b2) of SUMO1 (Figure 5B).
This portion of the b sheet was stabilized by a network of
hydrogen bonds between the backbone of PML (residues
555–559) and the backbone of SUMO1 (residues 35–37). In
this configuration, the side chains of PML residues V556 and
V558 were partially exposed to the solvent, whereas those of
residues V557 and I559 were buried within a hydrophobic
groove of SUMO1 composed of the a1 helix and the b2 strand.
The hydrophobic region of the phosphoSIM was stabilized by
contacts with the side chains of Y21, K23, I34, H35, F36, K37,
V38, K46, L47, and R54 from SUMO1. In addition, the residues
immediately N-terminal to the hydrophobic region (E554 and
R555) provided additional contacts to SUMO1. Notably, the
Nε atom of R555 of PML formed a hydrogen bond with the
backbone of E33 from SUMO1, while the terminal guanidino
group participated in a water-mediated hydrogen bond network
with SUMO1.
Consistent with the results from the BRET, ITC, and NMR
studies, the three phosphoserine residues (S560, S561, and
S562) immediately adjacent to the hydrophobic region were
visible in the electron density maps (Figure 5A), and the phos-
phate moiety of each residue was making contact with SUMO1
residues in the complex (Figure 5B). More precisely, the phos-
phate moiety of S560 formed a hydrogen bond with K46, the
phosphate moiety of S561 formed an electrostatic interaction
with K39, and the phosphate moiety of S562 formed hydrogen
bonds with H43. In contrast, the fourth serine residue (S565)
did not appear to be stabilized by interactions with SUMO1 in
the crystal structure, but previous studies have shown that it is
crucial for the subsequent phosphorylation of S562 byCK2 (Sca-
glioni et al., 2006).
To verify that the phosphates groups of PML specifically
contribute to binding to SUMO1, we obtained crystals of the
same SUMO1 construct in complex with the PML-SIM peptide
in the unphosphorylated form. The crystals of the DN-SUMO1:
PML-SIM complex belong to the same P212121 space group
and diffract to a resolution of 1.46 A˚ (Table 1). In contrast towith those obtained in the titration between 15N-labeled SUMO1 and the PML-
SIM peptide. The differences in chemical shift changes for the two individual
titrations were calculated using the formula Dd = [(0.17DNH)
2 + (DHN)
2]1/2.
(C) Ribbon model of the 3D structure of SUMO1 (light gray; PDB ID 2UYZ). The
amino acids of 15N-labeled SUMO1 showing a significant chemical shift
change (Dd [ppm] > 0.15) upon formation of a complex with PML-SIM-PO4 are
highlighted in green.
See also Figure S2.
hts reserved
Table 1. Data Collection and Refinement Statistics
Data Set SUMO1:PML-SIM-WT SUMO1:PML-SIM-PO4 SUMO1:DAXX-SIM-WT SUMO1:DAXX-SIM-PO4
Data Collection
Beamline X29, NSLS 08-ID, CLS X25, NSLS X25, NSLS
Wavelength (A˚) 1.075 0.9794 1.100 1.100
Space group P212121 P212121 P21 P21
Unit-cell parameter (A˚) A = 38.39, b = 47.25,
c = 63.91
a = 38.27, b = 47.08,
c = 63.98
a = 34.64, b = 38.40,
c = 73.69, b = 101.09
a = 34.27, b = 38.07,
c = 73.95, b = 101.04
Resolution (A˚) 50-1.46 (1.54–1.46) 50-1.50 (1.58–1.50) 50-1.35 (1.42–1.35) 50-1.70 (1.79–1.70)
No. of unique reflections 20,770 18,558 39,759 20,835
Multiplicity 6.8 (5.6) 9.8 (6.0) 3.1 (2.1) 3.3 (3.3)
Completeness (%) 99.2 (95.4) 96.9 (81.8) 94.6 (74.6) 99.9 (100.0)
Rmerge 0.092 (0.597) 0.112 (0.870) 0.036 (0.366) 0.042 (0.412)
I/s(I) 11.6 (2.7) 11.5 (2.1) 16.1 (2.4) 15.3 (2.6)
Refinement Statistics
Resolution (A˚) 50-1.46 50-1.50 50-1.35 50-1.70
Reflections (total/test)a 20,720/1,037 18,509/926 39,748/2,005 20,821/1,051
Rwork/Rfree (%) 15.66/18.38 15.83/19.21 15.58/18.09 16.28/19.52
No. of atoms (excluding hydrogens)
Protein 752 782 1,442 1,476
Water 148 146 333 177
B factors
Protein 18.69 19.64 21.57 34.02
Water 36.15 37.86 35.69 42.33
Rmsds
Bond lengths (A˚) 0.010 0.010 0.009 0.012
Bond angles () 1.363 1.298 1.235 1.253
Ramachandranb
Favored (%) 100.0 100.0 97.1 98.2
Outliers (%) 0 0 0 0




i jIhkl,i  < Ihkl > j /
P
hkl,i < Ihkl >, where Ihkl,i is the intensity of an individual mea-
surement of the reflection with Miller indices hkl and Ihkl is the mean intensity of that reflection. Rwork =
P
hkl k Foj  jFc k /
P
hkl jFoj, where jFoj is the
observed structure-factor amplitude and jFcj is the calculated structure-factor amplitude. Rfree is the R factor based on at least 500 test reflections that
were excluded from the refinement.
aReflections with Fo > 0.
bMolProbity analysis.
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Structure of the PhosphoSIM of PML Bound to SUMO1what was observed in the structure of the DN-SUMO1:PML-
SIM-PO4 complex, where the four phosphoserine residues
were visible in the electron density maps, S560 was the only
serine residue visible in the electron density map of the SUMO1:
PML-SIM complex (Figure 5C). In addition, we did not observe
an interaction between S560 of PML and K46 of SUMO1 (Fig-
ure 5D); this indicated that phosphorylation effectively contrib-
utes to the stabilization of the serine residues adjacent to the
hydrophobic residues of the phosphoSIM of PML. As expected,
the positions of the four hydrophobic residues of the phospho-
SIM were identical in both complexes, and this was in good
agreement with previous structural studies describing the
mode of interaction of the four hydrophobic residues of SIMs
(Armstrong et al., 2012; Chang et al., 2011; Reverter and Lima,
2005; Sekiyama et al., 2008; Song et al., 2005). Importantly,
the specific interactions involving the three phosphoserine resi-
dues in the SUMO1: PML-SIM-PO4 structure were consistent
with the BRET, ITC, and NMR data, which indicated that PMLStructure 23, 12phosphorylation increases its affinity for SUMO1 and highlighted
the roles that K39, H43, and K46 of SUMO1 contribute to the
binding interface.
The Hydrophobic and Serine Residues of the
PhosphoSIM Both Impact PML Tumor Suppression
Function
To assess whether PML tumor suppression activity is affected
by the affinity of the phosphoSIM for SUMO proteins and/or
SUMOylated partners, we generated mutations in either the hy-
drophobic (PML-VVVI-AAAS: the SIM hydrophobic residue mu-
tations of amino acids 556–559) or serine (PML-4SA) residues
of the phosphoSIM. The mutations were introduced into the
PML-IV isoform, since this is the only isoform known to induce
senescence (Bischof et al., 2002). To test the activity of the
PML phosphoSIM mutants, we chose the human osteosarcoma
cell line U2OS, a cell line in which PML-IV has been shown to act
as a tumor suppressor (Vernier et al., 2011). Our results showed6–138, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 131
Figure 5. Crystal Structures of the DN-SUMO1:PML-SIM-PO4 and DN-SUMO1:PML-SIM Complexes
(A) Electron density map corresponding to residues 552–562 of PML-SIM-PO4. The peptide is in stick representation with carbon atoms colored in yellow. The
2FoFc electron density map, contoured at 0.8s, is represented by a gray mesh.
(B) Overall structure of the DN-SUMO1:PML-SIM-PO4 complex highlighting the interactions between SUMO1 and residues 552–562 of PML (PDB entry 4WJN).
The proteins are in cartoon representation with DN-SUMO1 carbon atoms (gray) and PML-SIM-PO4 peptide carbon atoms (yellow); DN-SUMO1 residues in-
teracting with the PML-SIM-PO4 peptide are in stick representation.
(C) Electron density map corresponding to PML-SIM residues 552–560 and using the same representation mode as in (A) with PML carbon atoms colored in
green.
(D) Overall structure of the DN-SUMO1:PML-SIM complex highlighting the interactions between SUMO1 and PML (PDB entry 4WJO). The presentation is similar
to (C) with PML carbon atoms colored in green.
See also Figure S3.
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Structure of the PhosphoSIM of PML Bound to SUMO1that, upon stable exogenous expression of PML-IV in U2OS
cells, growth was slower than in U2OS expressing only the
empty vector (Figure 6A). Surprisingly, expression of either of
the two PML-IV phosphoSIM mutants demonstrated an
increased repressive effect on U2OS growth in comparison to
wild-type PML-IV (Figure 6A). However, this difference in growth
was not a direct consequence of expression levels of the pro-
teins in the established U2OS cell lines, as neither phosphoSIM
mutant displayed a higher steady-state expression level
compared with the wild-type PML-IV protein (Figure 6B).
Since examining the form and number of the PML-NBs is often
used to assess the functionality of PML, we performed immuno-
fluorescence studies against PML in the U2OS cell lines express-
ing the control vector, wild-type PML-IV, the PML-VVVI-AAAS
mutant, or the PML-4SA mutant. In all cases, overexpression
of the PML proteins (along with the endogenous PML) resulted
in an increase in both the number and the size of the PML-NBs
in the cell nucleus (Figure 6C). Interestingly, the most dramatic
increases appeared to be with the two phosphoSIM mutants of
PML. Overall, the results demonstrated that lowering the poten-132 Structure 23, 126–138, January 6, 2015 ª2015 Elsevier Ltd All rigtial of the phosphoSIM of PML to interact with SUMO and/or
SUMOylated proteins does alter the tumor suppression effects
of PML-IV without preventing formation of PML-NBs in cancer
cells expressing endogenous PML. Of note, only nonsumoylat-
able PML-IV mutants have been shown previously to maintain
tumor suppression activity (Bischof et al., 2002), but our results
demonstrated that PML phosphoSIM binding is also not required
and can be modulated.
Structure of the SUMO1:Daxx-SIM-PO4 Complex
Several proteins that are found in PML-NBs contain a phospho-
SIM similar to the one found in PML (Figure S1B; Cho et al., 2009;
Lin et al., 2006; Rasheed et al., 2002; Sung et al., 2011). In the
case of Daxx, it has been shown that phosphorylation of two
serine residues in its phosphoSIM motif increases its binding af-
finity to SUMO1 and plays a key role in regulating a number of its
biologic functions (Chang et al., 2011). To determine whether the
phosphorylation state of the phosphoSIM of Daxx affects its
binding to SUMO1 in a manner similar to that observed for
PML, we attempted to solve the structure of a peptide from thehts reserved
Figure 6. In Vivo Effect of Expressing
PML-IV Wild-Type or PhosphoSIM Mutants
in U2OS Cells
(A) Growth curves for U2OS cells stably express-
ing a control (Vect), a PML-IV (PML-wt), a PML-
4SA mutant, or a PML-VVVI-AAAS mutant. Data
are represented as mean of triplicates monitored
over a 9-day growth period, and statistical analysis
(t test) for the mutants was performed relative to
the PML-wt. * p < 5 3 104, ** p < 5 3 105.
(B) Immunoblots of PML and tubulin in U2OS cells
as in (A).
(C) Indirect immunofluorescence with an anti-PML
antibody and DAPI, nuclear marker, to visualize
PML-NBs in U2OS cells, as in (A).
Structure
Structure of the PhosphoSIM of PML Bound to SUMO1phosphoSIM of Daxx bound to SUMO1. The phosphoSIM of
Daxx (residues 733–740) is composed of an I-I-V-L hydrophobic
sequence immediately followed by an S-D-S-D sequence, where
the two serine residues are CK2 substrates (Chang et al., 2011).
The structure of a SUMO1-Daxx-SIM peptide complex in the un-
phosphorylated state has been characterized previously by
NMR spectroscopy. In addition, ITC studies demonstrated that
phosphorylation of the two serine residues increases the affinity
of the Daxx-SIM peptide for SUMO1 55-fold (Chang et al., 2011).
Initial attempts to crystallize either SUMO1 or DN-SUMO1 in
complex with a Daxx-SIM peptide in either the phosphorylated
or unphosphorylated state were unsuccessful. Careful examina-
tion of the crystal structures of DN-SUMO1 bound to the PML-
SIM peptides suggested that five residues at the N terminus
of the PML peptides established contacts that helped stabilize
the crystal lattice. We therefore created a modified version of
the Daxx-SIM peptide, termed mDaxx-SIM, containing the five
residues from PML that make the crystal contacts as an N-termi-Structure 23, 126–138, January 6, 2015nal tag. Importantly, this strategy allowed
for the crystallization of both a DN-
SUMO1:mDaxx-SIM-PO4 and a DN-
SUMO1:mDaxx-SIM complex (Table 1;
Figure S4). The DN-SUMO1:mDaxx-
SIM-PO4 crystals diffracted to 1.70-A˚
resolution, belong to the P21 space
group, and contain two DN-SUMO1:
mDaxx-SIM-PO4 complexes in the asym-
metric unit. Residues 733 to 740 of
mDaxx-SIM-PO4 peptide were visible in
one subunit, whereas only residues 733
to 737 were visible in the other. Likewise,
the DN-SUMO1:mDaxx-SIM crystals dif-
fracted to 1.35-A˚ resolution, belong to
the P21 space group, and contain two
DN-SUMO1:mDaxx-SIM complexes in
the asymmetric unit. However, in both
subunits only residues 733 to 737 of the
mDaxx-SIM peptide were visible.
The structures of the mDaxx-SIM-PO4
and mDaxx-SIM peptides in complex
with SUMO1 presented several simili-
tudes with the structures of the PML-
SIM-PO4 and PML-SIM peptides boundto SUMO1. As expected, the hydrophobic portions of the
mDaxx-SIM peptides adopted similar conformation to the cor-
responding portion of the PML-SIM peptides, and the same
residues that stabilized the phosphoSIM of PML also stabilized
the phosphoSIM of Daxx (Figure 7A). Moreover, the two phos-
phoserines (S737 and S739) of the Daxx-SIM-PO4 peptide
occupied similar positions as the first (S560) and third (S562)
phosphoserines of the PML-SIM-PO4 peptide (Figure 7B). How-
ever, K46 of SUMO1 did not seem to have a specific role in
stabilizing the S737 phosphoserine of the mDaxx-SIM-PO4
peptide, as was seen with S560 phosphoserine of PML, but
rather it appeared to provide a generally favorable environment
for the presence of both phosphoserines while accommodating
the bulkier hydrophobic region of the Daxx phosphoSIM
through its aliphatic moiety. The structures of the PML-SIM-
PO4 and mDaxx-SIM-PO4 peptides bound to SUMO1 also
differed noticeably with respect to the position of the negatively
charged residue in position two after the hydrophobic residues.ª2015 Elsevier Ltd All rights reserved 133
Figure 7. Structural Comparison of the DN-SUMO1:PML-SIM-PO4
and DN-SUMO1:mDaxx-SIM-PO4 Complexes
(A) Structure of the DN-SUMO1:mDaxx-SIM-PO4 complex highlighting the
interactions between SUMO1 and residues 733–740 of Daxx (PDB entry
4WJP). The proteins are in cartoon representation with DN-SUMO1 carbon
atoms (gray) and mDaxx-SIM-PO4 peptide carbon atoms (cyan); DN-SUMO1
residues interacting with mDaxx-SIM-PO4 are in stick representation.
(B) Structural comparison of the phosphorylated/acidic region of the phos-
phoSIMs of PML and Daxx (cyan) in the phosphorylated form. The proteins are
in cartoon representation with the DN-SUMO1 carbon atoms (gray), the PML-
SIM-PO4 peptide carbon atoms (yellow), and the mDaxx-SIM-PO4 peptide
carbon atoms (cyan); DN-SUMO1 residues interacting with the mDaxx-SIM-
PO4 peptide are in stick representation.
See also Figure S4.
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134 Structure 23, 126–138, January 6, 2015 ª2015 Elsevier Ltd All rigThe second phosphoserine (S561) of the PML-SIM-PO4 peptide
was stabilized by an interaction with the positive charge from
K39 of SUMO1, whereas D738 in the equivalent position in
mDaxx-SIM-PO4 peptide was at hydrogen bond distance from
both the hydroxyl group of T42 of SUMO1 and a water molecule
(Figure 7B). Interestingly, this water molecule also was co-
ordinated by the backbone amide of T42 and by the phosphate
moiety of the second phosphoserine of the mDaxx-SIM-PO4
peptide. Based on these structures, it appeared that, in their
phosphorylated form, the phosphoSIM of Daxx was bound to
SUMO1 through a similar but not identical mechanism com-
pared to the phosphoSIM of PML. This suggests that subtle
spacing patterns of the acidic and serine residues within phos-
phoSIMs can play an important role in their binding to SUMO
proteins (Figure S1B).
DISCUSSION
Despite the important functional role of phosphoSIMs in several
proteins, very little is known about how the phosphorylated
amino acids within the phosphoSIM enhance the binding affinity
for SUMO proteins at the atomic level (Chang et al., 2011;
Stehmeier and Muller, 2009). Using PML as a model, we have
characterized the role phosphorylation plays in the binding of
the phosphoSIM of PML to SUMO1 at the atomic level using a
combination of functional, biophysical, and structural studies.
We established that PML binding to SUMO1 is strongly en-
hanced by phosphorylation of four serine residues within the
phosphoSIM of PML. Consistent with the increased binding af-
finity observed both in vivo with full-length PML and in vitro
with a PML-SIM-PO4 peptide, the crystal structures of the
SUMO1:PML-SIM-PO4 and SUMO1:PML-SIM complexes re-
vealed that three phosphorylated serine residues within the
PML-SIM-PO4 peptide make specific contacts with positively
charged residues on the surface of SUMO1. We also demon-
strated that both the hydrophobic residues and the phosphory-
lated residues within the phosphoSIM of PML function in unison
to regulate both the tumor suppression properties of PML and
PML-NB formation. In addition, the crystal structure of the
SUMO1:mDaxx-SIM-PO4 complex with SUMO1 indicates that
in its phosphorylated form the phosphoSIM of Daxx makes
similar but nonidentical contacts at the interface with SUMO1
as those observed for the phosphoSIM of PML.
Our structures of the SUMO1:PML-SIM-PO4 and SUMO1:
PML-SIM complexes provide an atomic level description into
the role that phosphorylation plays in the binding of the phospho-
SIM of PML to SUMO1. Comparison of these peptide complexes
to previously characterized SUMO:SIM-containing complexes
revealed both similarities and differences between the PML
phosphoSIM and other canonical SIMs. Like several canonical
SIMs, the hydrophobic core of the PML phosphoSIM contacted
hydrophobic residues in a groove of SUMO1 and adopted a par-
allel orientation with respect to the b2 strand of SUMO1 (Arm-
strong et al., 2012; Olsen et al., 2010; Reverter and Lima,
2005; Sekiyama et al., 2008; Song et al., 2005). In addition, the
hydrophobic portion of the SIM sequence was followed immedi-
ately by a cluster of serine and/or negatively charged residues
that did not strongly participate in the stabilization of the interac-
tion with SUMO1 in the unphosphorylated SUMO1:PML-SIMhts reserved
Structure
Structure of the PhosphoSIM of PML Bound to SUMO1complex (Chang et al., 2011; Sekiyama et al., 2008; Song et al.,
2005).
This is consistent with previous NMR structures of the
SUMO1:PIAS2-SIM and SUMO3-MCAF1-SIM complexes in
their unphosphorylated forms (Sekiyama et al., 2008; Song
et al., 2005). Indeed, no specific contacts were observed be-
tween the SUMO proteins and the cluster of serine/acidic resi-
dues adjacent to either the PIAS2 orMCAF1 SIM sequences (Se-
kiyama et al., 2008; Song et al., 2005). In contrast, the interaction
module of the PML-SIM-PO4 peptide was extended, due to the
presence of the phosphorylated serine residues, and could be
perceived as two distinct submodules, one corresponding to
the hydrophobic residues and one encompassing the first three
phosphorylated residues (S560PO4-S561PO4-S562PO4) immedi-
ately adjacent to the hydrophobic residues. Thus, the extended
interaction interface seen in the SUMO1:PML-SIM-PO4 complex
required the phosphorylated serine residues. More specifically,
the SUMO1:PML-SIM-PO4 structure revealed that S560PO4,
S561PO4, and S562PO4 generated three additional interactions
with three distinct residues of SUMO1, respectively K46, K39,
and H43. Interestingly, phosphorylation of the fourth serine res-
idue (S565) in the PML serine/acidic residue cluster did not
appear to make a specific interaction with SUMO1 in the crystal
structure, since no corresponding density could be observed
in the electron density maps. This suggests that S565PO4 was
not directly contributing to the binding of the PML phosphoSIM
to SUMO1, but rather was required for the subsequent phos-
phorylation of S562 (Scaglioni et al., 2006), which did contri-
bute directly to the binding to SUMO1 through an interaction
with H43.
Interestingly, a number of proteins known to reside and/or
transiently interact with the PML-NBs also contain phosphoSIM
modules similar to the one in PML, and evidence suggests that
the homeostasis of the PML-NBs is governed by SUMO-depen-
dent noncovalent binding that is regulated in part by phosphor-
ylation events (Lin et al., 2006; Rabellino et al., 2012; Scaglioni
et al., 2006; Stehmeier and Muller, 2009). Comparing our crystal
structures of the SUMO1:PML-SIM-PO4 and SUMO1:mDaxx-
SIM-PO4 complexes indicated that there were similarities as
well as intriguing differences between the two phosphoSIMs.
Like the PML-SIM-PO4 peptide, the mDaxx-SIM-PO4 peptide
bound to SUMO1 in a more extended form that could be viewed
as two submodules, with both the hydrophobic and phosphory-
lated regions of the phosphoSIMmaking important contributions
to the binding interface. As expected, the hydrophobic regions of
the SIM and the phosphorylated SIM bound in very similar
manners, which was consistent with what has been observed
in the structures of several other SIMs bound to SUMO proteins.
However, the interactions involving the phosphorylated regions
were slightly more complex.
In the case of Daxx, the phosphoSIM contained two phos-
phorylated serine residues (S737PO4 and S739PO4) separated
by an aspartic acid (D738) in the first three positions immediately
adjacent to the hydrophobic residues, as opposed to three phos-
phoserines (S560PO4, S561PO4, and S562 PO4) located in the
same positions in the phosphoSIM of PML (Chang et al., 2011;
Scaglioni et al., 2006). This aspartic acid between the two phos-
phoserines alters the interaction of the first two positions
following the hydrophobic residues with SUMO1 with respectStructure 23, 12to what was observed with the three phosphoserines of PML.
Whereas a direct contact was seen between the phosphate
group of S560PO4 from PML and K46 of SUMO1, the phosphate
fromS737PO4 of Daxxwas not in position tomake the same inter-
action. The negatively charged phosphate of S561PO4 from PML
made direct contact with the positive charge of K39 from
SUMO1, whereas D738 from Daxx was at hydrogen bond dis-
tance from the hydroxyl group of T42 of SUMO1 and a water
molecule. Thus, a simple substitution of an aspartic acid for a
phosphoserine in the second position after the hydrophobic re-
gion changed the interaction pattern in the first two positions
of the phosphomodule with SUMO1. Based on these results, it
appeared that the precise arrangement of phosphoserines,
phosphothreonines, aspartic acids, and glutamic acids in the
positions immediately after the hydrophobic regions can have
a significant impact on the interactions with positively charged
residues on the SUMO proteins.
It has been suggested that one potential function of the acidic
and/or phosphorylated residues within the phosphoSIMs is to
define binding specificity for distinct SUMO family proteins
(Chang et al., 2011; Hecker et al., 2006). In support of this
idea, a recent study described an interconnection between
phosphoSIMs and acetylation of SUMO proteins that led to a
higher-order level of selectivity (Ullmann et al., 2012). Based on
the differences we observed in the crystal structures of the
SUMO1:PML-SIM-PO4 and SUMO1:mDaxx-SIM-PO4 com-
plexes, it appears that different arrangements of negatively
charged (D and E) and phosphorylated (S and T) residues within
the phosphoSIM could help define this specificity for different
SUMO proteins depending on their respective phosphorylation
(Figure S1B) and acetylation states. SUMO1 can be acetylated
at several lysines (K37, K39, K45, K46, and K48) (Cheema
et al., 2010; Choudhary et al., 2009; Ullmann et al., 2012), and
three of these lysines (K37, K39, and K46) made contacts with
the phosphoSIM of PML in the SUMO1-PML-SIM-PO4 complex.
More precisely, the positive charges of K46 and K39 made con-
tact with the phosphate groups of S560PO4 and S562 PO4,
respectively, whereas the aliphatic portion of the side chain of
K37 made van der Waals contact with V558 from the phospho-
SIM of PML. In the case of the SUMO1-mDaxx-SIM-PO4 com-
plex, the van der Waals contact between K37 of SUMO1 and
V735 of Daxx was very similar to what was observed between
K37 and V558 of PML. However, no direct contacts were
observed between the phosphoSIM of Daxx and either K39 or
K46 of SUMO1. This suggests that acetylation of either of these
two lysine residues could have different impact on SUMO1 bind-
ing to PML versus Daxx.
Interestingly, these results also explain howacidic and/or phos-
phorylatable residues at the third position of the hydrophobic core
could also contribute to the specificity for SUMO proteins. In the
NMR structures of the SUMO1:PIAS2-SIM and SUMO3-MCAF1-
SIM complexes (Sekiyama et al., 2008; Song et al., 2005), the
negative charge of an aspartic acid residue at the third position
of the hydrophobic corewithin the SIM interactedwith the positive
charge of K37 or K33 of SUMO1 and SUMO2, respectively. This
is in contrast to the van der Waals interaction that was observed
with valine residues in the same position of the phosphoSIMs
of PML and Daxx. Taken together, our structures of the SUMO1:
PML-SIM-PO4 and SUMO1:mDaxx-SIM-PO4 complexes in6–138, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 135
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provide atomic level insights into how phosphorylated residues
in phosphoSIMs from various proteins in PML-NBs contribute
to binding to SUMO proteins. In addition, the results indicate
how different spacing patterns of acidic/phosphorylated residues
within both modules of the phosphoSIM, hydrophobic and phos-
phorylated (Figure S1B), can interconnect with the acetylation
patterns of the different SUMO family proteins to control specific
interactions. Biologically, this can be particularly relevant to the
diverse functions attributed to PML-NBs, as exemplified by the
different growth rate reductions that U2OS cells experienced (Fig-





The PML BRET constructs have been described previously (Percherancier
et al., 2009). The nonconjugable version of human SUMO1 fused to pGFP10
was generated by site-directed mutagenesis from pGFP10-SUMO1, mutating
the SUMO diglycine motif to alanine residues (Mascle et al., 2007). All SUMO1
mutants were generated by site-directed mutagenesis starting from the non-
conjugable form of SUMO1.
Recombinant Protein Constructs
The sequences for the PML-SIM peptides (residues 547–573; PML-I) were
ordered as oligonucleotides (Integrated DNA Technologies) and cloned as a
BamHI-EcoRI fragment into pGEX-2T vector (Amersham). SUMO1 (residues
2–97 of human SUMO1) cDNA was PCR amplified from pGFP10-SUMO1
and cloned as an XbaI fragment into pGEX-4T3 vector (Amersham). A
SUMO1-C52A point mutant was generated using site-directed mutagenesis.
A DN-SUMO1 construct (residues 17–97 with the C52A mutation) was cloned
into a modified pGEX-2T vector with a tobacco etch virus protease cut. Con-
structs were verified by DNA sequencing.
Retroviral Expression Vectors
The retroviral vectors pLPC and pLPC-PML-IV have been described previ-
ously (Ferbeyre et al., 2000). Mutations of either the hydrophobic (556-
AAAS-559) or four serine (S560A, S561A, S562A, and S565A) residues were
obtained by site-directed mutagenesis of pLPC-PML-IV.
BRET Experiments
The BRET assays were conducted as described previously (Percherancier
et al., 2009). For details, see Supplemental Experimental Procedures.
Expression and Purification of Proteins
SUMO1,DN-SUMO1, and PML-SIMwere expressed as GST fusion proteins in
E. coli host strain TOPP2 (Stratagene) and purified. For details of purification,
see Supplemental Experimental Procedures.
In Vitro Phosphorylation and Purification
The tetraphosphorylated PML-SIM-PO4 peptide was generated from the PML-
SIM peptide by incubationwith CK2 (New England Biolabs). See Supplemental
Experimental Procedures for details.
Peptide Synthesis
The mDaxx-SIM (GSGEAEERIIVLpSDpSDY) and mDaxx-SIM-PO4
(GSGEAEERIIVLSDSDY) peptides were chemically synthesized using Fmoc
chemistry. See Supplemental Experimental Procedures for details.
ITC Experiments
Proteins were dialysed overnight against buffer (20 mM Tris-HCl, pH 7.4). ITC
measurements were performed at 25C using a VP-ITC calorimeter (GE
Healthcare). All titration experiments were done in duplicate and fit to a single
binding site interaction with 1:1 stoichiometry. The baseline-corrected data
were fit with Origin 7 software. See Supplemental Experimental Procedures
for details.136 Structure 23, 126–138, January 6, 2015 ª2015 Elsevier Ltd All rigNMR Spectroscopy
NMR chemical shift perturbation experiments were carried out at 300K on
either a Varian Unity Inova 500 or 600MHz spectrometer. For details, see Sup-
plemental Experimental Procedures.
Crystallization and Data Collection
Crystals of each complex were obtained by the hanging drop vapor diffusion
method and data were collected at the Canadian Light Source (CLS) or
National Synchrotron Light Source (NSLS). See Supplemental Experimental
Procedures for details.
Structure Determination and Refinement
Initial phases were obtained by molecular replacement using the crystal struc-
ture of DN-SUMO1 (Protein Data Bank [PDB] ID 2UYZ) as a search template.
Phases were improved by iterative cycles of model building with Coot and
refinement with Phenix. Test data sets were randomly selected from the
observed reflections prior to refinement. The figures were prepared with
PyMOL.
Cell Proliferation, Immunoblotting, and Immunofluorescence
Cell proliferation assays in U2OS cells (Ferbeyre et al., 2000), immunoblots
(Ferbeyre et al., 2000), and immunofluorescence experiments (Vernier et al.,
2011) were performed as described previously. See Supplemental Experi-
mental Procedures for details on these assays.
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